Expert Discusses Formulary Changes in Oncology Biosimilars at AMCP Annual Meeting

In an interview with Pharmacy Times®, Eric Tichy, PharmD, MBA, BCPS, FAST, FCCP, Vice Chair of Pharmacy/Formulary at Mayo Clinic, discusses some formulary trends in biosimilars at the Academy of Managed Care Pharmacy Annual Meeting.

In an interview with Pharmacy Times®, Eric Tichy, PharmD, MBA, BCPS, FAST, FCCP, Vice Chair of Pharmacy/Formulary at Mayo Clinic, discussed some formulary trends in the oncology biosimilars space at the Academy of Managed Care Pharmacy Annual Meeting.

Q: What are some formulary trends in the oncology biosimilars space this year?

Eric Tichy: Well, the oncology biosimilar space is really taking off. We've seen that the biosimilars are now more than half of the purchases of those therapeutic agents. So that's kind of a big inflection point where we hadn't seen that with other biosimilars.